
1. aids. 2008 nov 12;22(17):2279-89. doi: 10.1097/qad.0b013e328311d16f.

viral resuppression detection drug resistance following interruption 
suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.

fox z, phillips a, cohen c, neuhaus j, baxter j, emery s, hirschel b, hullsiek
kh, stephan c, lundgren j; smart study group.

collaborators: lundgren jd, jensen kb, gey dc, borup l, pearson m, jansson po,
jensen bg, tverland j, juncker-benzon h, fox z, phillips an, darbyshire jh,
babiker ag, palfreema aj, fleck sl, dodd w, king e, cordwell b, van hooff f,
collaco-moraes y, cooper da, emery s, drummond fm, connor sr, satchell cs, gunn
s, oka s, delfino ma, merlin k, mcginley c, gordin f, finley e, dietz d, chesson 
c, vjecha m, standridge b, neaton jd, bartsch g, duchene a, george m, grund b,
harrison e, krun e, larson g, miller c, nelson r, neuhaus j, roediger mp, schultz
t, prineas r, campbell c, zhang zm, perez g, lifson a, duprez d, hoy j, lahart c,
perlman d, price r, prineas r, rhame f, sampson j, worley j, rein m, dersimonian 
r, brody ba, daar es, dubler nn, fleming tr, freeman dj, kahn jp, kim km, medoff 
g, modlin jf, moellering r jr, murray be, pick b, robb ml, scharfstein do,
sugarman j, tsiatis a, tuazon c, zoloth l, klingman k, lehrman s, lazovski j,
belloso wh, losso mh, benetucci ja, aquilia s, bittar v, bogdanowicz pe, cahn pe,
casiró ad, cassetti i, contarelli jm, corral ja, crinejo a, daciuk l, david do,
guaragna g, ishida mt, krolewiecki a, laplume he, lasala mb, lourtau l, lupo sh, 
maranzana a, masciottra f, michaan m, ruggieri l, salazar e, sánchez m, somenzini
c, hoy jf, rogers gd, allworth am, anderson js, armishaw j, barnes k, carr a,
chiam a, chuah jc, curry mc, dever rl, donohue wa, doong nc, dwyer de, dyer j, eu
b, ferguson vw, french ma, garsia rj, gold j, hudson jh, jeganathan s, konecny p,
leung j, mccormac cl, mcmurchie m, medland n, moore rj, moussa mb, orth d, piper 
m, read t, roney jj, roth n, shaw dr, silvers j, smith dj, street ac, vale rj,
wendt na, wood h, youds dw, zillman j, rieger a, tozeau v, aichelburg a, vetter
n, clumeck n, dewit s, de roo a, kabeya k, leonard p, lynen l, moutschen m,
o'doherty e, pereira lc jr, souza tn, schechter m, zajdenverg r, almeida mm,
araujo f, bahia f, brites c, caseiro mm, casseb j, etzel a, falco gg, filho ec,
flint sr, gonzales cr, madruga jv, passos rn, reuter t, sidi lc, toscano al,
zarowny d, cherban e, cohen j, conway b, dufour c, ellis m, foster a, haase d,
haldane h, houde m, kato c, klein m, lessard b, martel a, martel c, mcfarland n, 
paradis e, piche a, sandre r, schlech w, schmidt s, smaill f, thompson b,
trottier s, vezina s, walmsley s, wolff reyes mj, northland r, ostergaard l,
pedersen c, nielsen h, hergens l, loftheim ir, jensen kb, raukas m, zilmer k,
justinen j, ristola m, girard pm, landman r, abel s, abgrall s, amat k, auperin
l, barruet r, benalycherif a, benammar n, bensalem m, bentata m, besnier jm,
blanc m, bouchaud o, cabié a, chavannet p, chennebault jm, dargere s, de la
tribonniere x, debord t, decaux n, delgado j, dupon m, durant j, frixon-marin v, 
genet c, gérard l, gilquin j, hoen b, jeantils v, kouadio h, leclercq p, lelièvre
jd, levy y, michon cp, nau p, pacanowski j, piketty c, poizot-martin i, raymond
i, salmon d, schmit jl, serini ma, simon a, tassi s, touam f, verdon r, weinbreck
p, weiss l, yazdanpanah y, yeni p, fätkenheuer g, staszewski s, bergmann f,
bitsch s, bogner jr, brockmeyer n, esser s, goebel fd, hartmann m, klinker h,
lehmann c, lennemann t, plettenberg a, potthof a, rockstroh j, ross b, stoehr a, 
wasmuth jc, wiedemeyer k, winzer r, hatzakis a, touloumi g, antoniadou a, daikos 
gl, dimitrakaki a, gargalianos-kakolyris p, giannaris m, karafoulidou a,
katsambas a, katsarou o, kontos an, kordossis t, lazanas mk, panagopoulos p,
panos g, paparizos v, papastamopoulos v, petrikkos g, sambatakou h, skoutelis a, 
tsogas n, xylomenos g, bergin cj, mooka b, pollack s, mamorksy mg, agmon-levin n,
karplus r, kedem e, maayan s, shahar e, sthoeger z, turner d, yust i, tambussi g,
rusconi v, abeli c, bechi m, biglino a, bonora s, butini l, carosi g, casari s,
corpolongo a, de gioanni m, di perri g, di pietro m, doffizi g, esposito r,
mazzotta f, montroni m, nardini g, nozza s, quirino t, raise e, honda m, ishisaka
m, caplinskas s, uzdaviniene v, schmit jc, staub t, himmich h, marhoum el filali 
k, mills gd, blackmore t, masters ja, morgan j, pithie a, brunn j, ormasssen v,
la rosa a, guerra o, espichan m, gutierrez l, mendo f, salazar r, knytz b, horban
a, bakowska e, beniowski m, gasiorowski j, kwiatkowski j, antunes f, castro rs,
doroana m, horta a, mansinho k, miranda ac, pinto iv, valadas e, vera j,
rakhmanova a, vinogradova e, yakovlev a, zakharova n, wood w, orrel c, gatell j, 
arnaiz ja, carrillo r, clotet b, dalmau d, gonzález a, jordano q, jou a, knobel
h, larrousse m, mata r, moreno js, oretaga e, pena jn, pulido f, rubio r, sanz j,
viciana p, hirschel b, spycher r, battegay m, bernasconi e, bottone s, cavassini 
m, christen a, franc c, furrer hj, gayet-ageron a, genné d, hochstrasser s,
magenta l, moens c, müller n, nüesch r, phanuphak p, ruxrungtham k, pumpradit w, 
chetchotisakd p, dangthongdee s, kiertiburanakul s, klinbuayaem v, mootsikapun p,
nonenoy s, piyavong b, prasithsirikul w, raksakulkarn p, gazzard bg, ainsworth
jg, anderson j, angus bj, barber tj, brook mg, care cd, chadwick dr, chikohora m,
churchill dr, cornforth d, dockrell dh, easterbrook pj, fox pa, fox r, gomez pa, 
gompels mm, harris gm, herman s, jackson ag, jebakumar sp, johnson ma, kinghorn
gr, kuldanek ka, larbalestie n, leen c, lumsden m, maher t, mantell j, maw r,
mckernan s, mclean l, morris s, muromba l, orkin cm, palfreeman aj, peters bs,
peto te, portsmouth sd, rajamanoharan s, ronan a, schwenk a, slinn ma, stroud cj,
thomas rc, wansbrough-jones mh, whiles hj, white dj, williams e, williams ig,
youle m, abrams di, acosta ea, adams s, adamski a, andrews l, antoniskis d,
aragon dr, arduino r, artz r, bailowitz j, barnett bj, baroni c, barron m, baxter
jd, beers d, beilke m, bemenderfer d, bernard a, besch cl, bessesen mt, bethel
jt, blue s, blum jd, boardend s, bolan rk, borgman jb, brar i, braxton bk,
bredeek uf, brennan r, britt de, brockelman j, brown s, bruzzese v,
bulgin-coleman d, bullock de, cafaro v, campbell b, caras s, carroll j, casey kk,
chiang f, childress g, cindrich rb, clark c, climo m, cohen c, coley j, condoluci
dv, contreras r, corser d, cozzolino j, crane lr, daley l, dandridge d, d'antuono
v, patron darcourt rizo jg, dehovitz ja, dejesus e, desjardin j, diaz-linares m, 
dietrich c, dodson p, dolce e, elliott k, erickson d, estes m, faber ll, falbo j,
farrough mj, farthing cf, ferrell-gonzalez p, flynn h, frank c, frank m, freeman 
kf, french n, friedland g, fujita n, gahagan l, genther k, gilson i, goetz mb,
goodwin e, graziano f, guity ck, gulick p, gunderson er, hale cm, hannah k,
henderson h, hennessey k, henry wk, higgins dt, hodder sl, horowitz hw,
howe-pittman m, hubbard j, hudson r, hunter h, hutelmyer c, insignares mt,
jackson l, jenny l, john m, johnson dl, johnson g, johnson j, kaatz j, kaczmarski
j, kagan s, kantor c, kempner t, kieckhaus k, kimmel n, klaus bm, klimas n,
koeppe jr, koirala j, kopka j, kostman jr, kozal mj, kumar a, labriola a,
lampiris h, lamprecht c, lattanzi km, lee j, leggett j, long c, loquere a,
loveless k, lucasti cj, luskin-hawk r, macveigh m, makohon lh, mannheimer s,
markowitz np, marks c, martinez n, martorell c, mcfeaters e, mcgee b, mcintyre
dm, mckee j, mcmanus e, melecio lg, melton d, mercado s, merrifield e, mieras ja,
mogyoros m, moran fm, murphy k, mushatt d, mutic s, nadeem i, nahass r, nixon d, 
o'brien s, ognjan a, o'hearn m, o'keefe k, okhuysen pc, oldfield e, olson d,
orenstein r, ortiz r, osterberger j, owen w, parpart f, pastore-lange v, paul s, 
pavlatos a, pearce dd, pelz r, perez g, peterson s, pierone g jr, pitrak d,
powers sl, pujet hc, raaum jw, ravishankar j, reeder j, regevik n, reilly na,
reyelt c, riddell j 4th, rimland d, robinson ml, rodriguez ae, rodriguez-barradas
mc, rodriguez derouen v, roland r, rosmarin c, rossen wl, rouff jr, sampson jh,
sands m, savini c, schrader s, schulte mm, scott c, scott r, seedhom h, sension
m, sheble-hall a, sheridan a, shuter j, slater ln, slotten r, slowinski d, smith 
m, snap s, somboonwit c, states dm, stewart m, stringer g, sullivan j, summers
kk, swanson k, sweeton ib, szabo s, tedaldi em, telzak ee, temesgen z, thomas d, 
thompson ma, thompson s, ting hong bong c, tobin c, uy j, vaccaro a, vasco lm,
vecino i, verlinghieri gk, visnegarwala f, wade bh, watson v, weis se, weise ja, 
weissman s, wilkin am, williams l, witter jh, wojtusic l, wright tj, yeh v, young
b, zeana c, zeh j, savio e, vacarezza m.

background: interruption non-nucleoside reverse transcriptase inhibitor
(nnrti)-regimen often necessary, must performed caution because
nnrtis low genetic barrier resistance. limited data exist guide
clinical practice best interruption strategy use.
methods: patients drug-conservation arm strategies management
of antiretroviral therapy (smart) trial interrupted fully suppressive
nnrti-regimen evaluated. 2003, smart recommended interruption an
nnrti staggered interruption, nnrti stopped the
nrtis, replacing nnrti another drug interruption.
simultaneous interruption antiretrovirals discouraged. resuppression
rates 4-8 months reinitiating nnrti-therapy assessed, the
detection drug-resistance mutations within 2 months treatment
interruption subset (n = 141).
results: overall, 601/688 (87.4%) patients restarted nnrti achieved viral 
resuppression. adjusted odds ratio (95% confidence interval) achieving
resuppression 1.94 (1.02-3.69) patients staggered interruption and
3.64 (1.37-9.64) switched interruption compared patients
with simultaneous interruption. least one nnrti-mutation detected the
virus 16.4% patients simultaneous interruption, 12.5% patients with
staggered interruption 4.2% patients switched interruption. fewer
patients detectable mutations (i.e. 69.2%) achieved hiv-rna 400 copies/ml
or less compared mutations detected (i.e. 86.7%; p =
0.05).
conclusion: patients interrupt suppressive nnrti-regimen, choice 
interruption strategy may influence resuppression rates restarting similar
regimen. nnrti drug-resistance mutations observed relatively high
proportion patients. data provide additional support staggered 
switched interruption strategy nnrti drugs.

doi: 10.1097/qad.0b013e328311d16f 
pmcid: pmc2745911
pmid: 18981767  [indexed medline]

